Primitive Hepatoblasts Driving Early Liver Development
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jun 2025 · 1 min read
In brief
In brief
Researchers identify a novel population of primitive hepatoblasts originating from CDX2-positive endoderm that contribute to early liver development through WNT-suppression signaling. These cells exhibit hybrid epithelial-mesenchymal characteristics and can be derived from human pluripotent stem cells, offering new insights into modeling normal and abnormal hepatogenesis.
Written by the GCMD Library team from the article.
Statements in this article
Hepatoblasts originate from the ventral foregut endoderm adjacent to the heart during embryonic liver development.
A previously unrecognized population of early hepatoblasts exists at the ventroposterior part of the emerging liver bud, traced from Cdx2-positive endoderm progenitors.
Primitive hepatoblasts express canonical hepatoblast markers TBX3, FGB, and KRT8/18 as well as primitive-specific mesenchymal markers ID3, VIM, and GATA4.
Primitive hepatoblasts contribute up to 12.6% of LIV2+ hepatoblasts at E11.5 in mouse development.
The contribution of primitive hepatoblasts diminishes in late fetal and postnatal development.
Primitive hepatoblast emergence is primed by WNT-suppression on RA-permissive CDX2+FOXA2+ progenitors.
Human pluripotent stem cell-derived primitive hepatoblast-like cells secrete pleiotrophin and midkine to amplify hepatoblast populations.
Primitive hepatoblast-like cells develop epithelial-mesenchymal hybrid tissues in vivo.